Search

everythinglearnresearchcommunity

for

Search:↓

Different types of female pattern hair loss have unique characteristics and are associated with various health conditions.

People with reproductive, thyroid disorders, and type 2 diabetes can experience voice changes, but more research is needed to understand this better.

A woman's severe male hormone excess was caused by a small, hard-to-find ovarian tumor.

Hormonal therapy like cyproterone acetate and spironolactone may help female hair loss, but more research is needed, especially for pre-menopausal women.

Estrogen helps improve skin aging and healing, especially in post-menopausal women.

Anorexia nervosa can harm fertility and increase pregnancy risks.

Hormonal therapies can improve skin issues by adjusting hormone levels, with future advancements promising better results.

Sex hormones likely don't affect atopic dermatitis in adolescents and adults.

Menopause causes skin and hair to become drier and thinner, but hormone therapy can improve these conditions.

A woman's high testosterone levels were caused by a rare ovarian tumor, not the initially diagnosed condition.

Androgenetic alopecia starts earlier in males than females, with different treatments, and is linked to income, education, alcohol use, and mental health.

Hormone treatment for transsexual individuals is effective but carries risks like thromboembolic events and mood changes, with most side effects being minor and reversible.

Oral contraceptives provide various health benefits beyond birth control, including managing menstrual issues, skin conditions, pain, and reducing the risk of certain cancers.

The rat model showed early perimenopause with regular cycles and low hormones, and late perimenopause with irregular cycles and higher hormone levels.

Certain hormone medications can treat symptoms like acne and unwanted hair, regulate periods, and prevent pregnancy in women and teenage girls.

A misdiagnosed case of HAIR-AN syndrome led to unnecessary surgeries and highlighted the importance of correct diagnosis and treatment.

Two new compounds were found to build bone and muscle without affecting reproductive organs and skin oil glands.

FFA is more common in postmenopausal women, can affect younger women, and may stabilize over time.

Minoxidil can stop the growth of ovarian cancer cells without harming the heart.

Transdermal testosterone can improve sexual desire in postmenopausal women but lacks long-term safety data and is not FDA-approved for this use.

Testosterone therapy seems safe for short-term use in postmenopausal women with low sexual desire, but more research on long-term effects is needed.

A 60-year-old man with a long-term balding condition also developed a rare hair loss condition usually seen in postmenopausal women.

Frontal fibrosing alopecia causes hairline recession and eyebrow loss in postmenopausal women.

Formestane is a preferred second-line treatment for advanced breast cancer in postmenopausal women because it's effective and has fewer side effects.

Woman with diabetes had hair loss due to rare ovarian tumor; surgery improved hair growth.

A young woman had a rare, aggressive ovarian tumor that was hard to diagnose and treat, leading to disease progression despite treatment.

Multimodal primary treatment improves survival in premenopausal breast cancer patients and is also beneficial for postmenopausal women.

Most women had adequate essential elements except zinc, and lead levels were higher in peri-/post-menopausal women.

Vitamin D and estrogen may help protect heart and kidney health, and maintaining sufficient vitamin D levels could be especially beneficial for African Americans, postmenopausal women, and people with chronic kidney disease.

Male hormones, particularly DHT, are linked to male pattern hair loss, and treatments like finasteride can help, but they don't work for postmenopausal women's hair loss, which may have different causes.